MTOR and cancer: Dysregulation of the PI3K/AKT/mTOR signaling pathway is frequently observed in cancers, and leads to pleiotropic effects, including modulation of autophagy, epithelial–mesenchymal transition (EMT), apoptosis, chemoresistance, cell survival, and metastasis [31,32,33].